The EBMT activity survey 2009: Trends over the past 5 years

Bone Marrow Transplantation

Volumn 46, Issue 4, 2011, Pages 485-501

  Baldomero, H ^a   Gratwohl, M ^b   Gratwohl, A ^a   Tichelli, A ^a   Niederwieser, D ^c   Madrigal, A ^d   Frauendorfer, K ^b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF ST GALLEN   (Switzerland)

^c UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^d ANTHONY NOLAN RESEARCH INSTITUTE   (United Kingdom)

Author keywords

Europe; hematopoietic SCT; indication; practice guidelines; stem cell source; transplant rates

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ALLOGENEIC STEM CELL TRANSPLANTATION; AUTOIMMUNE DISEASE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE MARROW TRANSPLANTATION; CARDIOVASCULAR DISEASE; CARTILAGE CELL; CELL THERAPY; CONTROLLED STUDY; DONOR LYMPHOCYTE INFUSION; EUROPE; FIBROBLAST; HEALTH SURVEY; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; KERATINOCYTE; LEUKEMIA; LOWEST INCOME GROUP; LYMPHOPROLIFERATIVE DISEASE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NEUROLOGIC DISEASE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REDUCED INTENSITY CONDITIONING; REVIEW; SOLID TUMOR; TISSUE REPAIR; TREATMENT INDICATION; TREND STUDY;

DATA COLLECTION; EUROPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; PRACTICE GUIDELINES AS TOPIC; TISSUE DONORS;

EID: 79953700536     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2011.11     Document Type: Review

References (23)

1. Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med 2006; 354: 1813-1826.
2. Appelbaum FR. Hematopoietic-cell transplantation at 50. N Engl J Med 2007; 357: 1472-1475. (Pubitemid 47572632)
3. Gratwohl A, Baldomero H, Aljurf M, Pasquini MC, Bouzas LF, Yoshimi A et al. Hematopoietic stem cell transplantation: a global perspective. JAMA 2010; 303: 1617-1624.
4. Aljurf M, Zaidi SZ, Hussain F, Ghavamzadeh A, Alimoghad-dam K, Jahani M et al. Status of hematopoietic stem cell transplantation in the WHO Eastern Mediterranean Region (EMRO). Transfus Apher Sci 2010; 42: 169-175.
5. Yoshimi A, Suzuki R, Atsuta Y, Iida M, Lu DP, Tong W et al. Hematopoietic SCT activity in Asia: a report from the Asia-Pacific Blood and Marrow Transplantation Group. Bone Marrow Transplant 2010; 45: 1682-1691.
6. Gratwohl A, Baldomero H, Schwendener A, Gratwohl M, Apperley J, Frauendorfer K et al. The EBMT activity survey 2008 impact of team size, team density and new trends. Bone Marrow Transplant 2011; 46: 174-191.
7. Gratwohl A. Bone marrow transplantation activity in Europe 1990. Report from the European Group for Bone Marrow Transplantation (EBMT). Bone Marrow Transplant 1991; 8: 197-201.
8. Gratwohl A, Baldomero H, Horisberger B, Schmid C, Passweg J, Urbano-Ispizua A. Accreditation Committee of the Eur-opean Group for Blood and Marrow Transplantation (EBMT). Current trends in haematopoietic stem cell trans-plantation in Europe. Blood 2002; 100: 2374-2386.
9. Gratwohl A, Baldomero H, Schwendener A, Gratwohl M, Apperley J, Niederwieser D et al. Predictability of hemato-poietic stem cell transplantation rates. Haematologica 2007; 92: 1679-1686. (Pubitemid 350248248)
10. Gratwohl A, Baldomero H, Schwendener A, Rocha V, Apperley J, Frauendorfer K et al. The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapies. Bone Marrow Transplant 2009; 43: 275-291.
11. Gratwohl A, Schwendener A, Baldomero H, Gratwohl M, Apperley J, Niederwieser D et al. Changes in use of hematopoietic stem cell transplantation: a model for diffusion ofmedical technology. Haematologica 2010; 95: 637-643.
12. World Health Organisation. WHO. (http://www.who.int/topics/ transplantation/en/).
13. Martin I, Baldomero H, Tyndall A, Niederwieser D, Gratwohl A. A survey on cellular and engineered tissue therapies in Europe in 2008. Tissue Eng Part A 2010; 16: 2419-2427.
14. Ljungman P, Bregni M, Brune M, Cornelissen J, deWitte T, Dini G et al. European Group for Blood and Marrow. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009. Bone Marrow Transplantation 2010; 45: 219-234.
15. Chu R, Brazauskas R, Kan F, Bashey A, Bredeson C, Camitta B et al. Comparison of outcomes after transplantation of G-CSF stimulated bone marrow grafts versus bone marrow or peripheral blood grafts from HLA-matched sibling donors for patients with severe aplastic anemia. Biol Blood Marrow Transplant 2010 (E-pub ahead of print).
16. Schrezenmeier H, Passweg JR, Marsh JC, Bacigalupo A, Bredeson CN, Bullorsky E et al. Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia. Blood 2007; 110: 1397-1400. (Pubitemid 47281442)
17. Mehta P, Locatelli F, Stary J, Smith FO. Bone marrow transplantation for inherited bone marrow failure syndromes. Pediatr Clin NAm 2010; 57: 147-170.
18. Koreth J, Schlenk R, Kopecky KJ, Honda S, Sierra J, Djulbegovic BJ et al. Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials. JAMA 2009; 301: 2349-2361.
19. Gooley TA, Chien JW, Pergam SA, Hingorani S, Sorror ML, Boeckh M et al. Reduced mortality after allogeneic hema-topoietic-cell transplantation. N Engl J Med 2010; 363: 2091-2101.
20. Kersey JH. The role of allogeneic-cell transplantation in leukemia. N Engl J Med 2010; 363: 2158-2159.
21. Meijer E, Cornelissen JJ. Allogeneic stem cell transplantation in acute myeloid leukemia in first or subsequent remission: weighing prognostic markers predicting relapse and risk factors for non-relapse mortality. Semin Oncol 2008; 35: 449-457.
22. Dreger P, Dohner H, Ritgen M, Bottcher S, Busch R, Dietrich S et al. German CLL Study Group. Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL Study Group CLL3X trial. Blood 2010; 116: 2438-2447.
23. De Witte T, Hagemeijer A, Suciu S, Belhabri A, Delforge M, Kobbe G et al. Value of allogeneic versus autologous stem cell transplantation and chemotherapy in patients with myelo-dysplastic syndromes and secondary acute myeloid leukemia. Final results of a prospective randomized European Intergroup Trial. Haematologica 2010; 95: 1754-1761.